Home Health Encounter + Patient Monitoring + Questionnaire Administration + NIVOLUMAB for squamous cell carcinoma of head and neck
A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set
Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.
Put together by software, not yet checked by a person
Why this status
20 Feb 2024: Trial registered, NCT06265285
30 Apr 2024: Trial started, NCT06265285
The trials
NCT06265285: Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
State
Under way
Phase
Phase 2
People
50 planned
Started
30 Apr 2024
Primary completion
1 May 2027
Arms
Health services research (in-clinic and at-home nivolumab)
Results
None posted
20 Feb 2024: Trial registered
30 Apr 2024: Trial started
How the status changed
19 Nov 2026: First set: Phase 2 trial
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.